<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05619601</url>
  </required_header>
  <id_info>
    <org_study_id>0099-2022-OBS</org_study_id>
    <nct_id>NCT05619601</nct_id>
  </id_info>
  <brief_title>Gender Differences in Prevention Strategies and Therapeutic Adherence After Acute Myocardial Infarction</brief_title>
  <acronym>GENAMI</acronym>
  <official_title>Gender Differences in Prevention Strategies and Therapeutic Adherence After Acute Myocardial Infarction - GENAMI PREVENTION</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spanish Society of Cardiology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spanish Society of Cardiology</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      PARTICIPANT CENTERS: 25 hospitals managing routinely acute myocardial infarction (AMI) and&#xD;
      representing different regions from Spain will be invited to participate.&#xD;
&#xD;
      GENERAL OBJECTIVE: To evaluate if there are differences in the level of adherence to&#xD;
      recommended secondary prevention therapies (pharmacological and non-pharmacological) between&#xD;
      women and men surviving a type 1 acute myocardial infarction (with obstructive coronary&#xD;
      artery disease), its potential consequences, and the potential factors related to that&#xD;
      difference, if present.&#xD;
&#xD;
      DESIGN:&#xD;
&#xD;
      Prospective, matched cohort study of patients hospitalized for a type 1 acute myocardial&#xD;
      infarction with evidence of obstructive coronary artery disease who are discharged home&#xD;
      alive. Women will be enrolled first, ideally in a consecutive manner, as they are the focus&#xD;
      of the study. Men will be recruited subsequently as the comparison group, with 1:1 matching&#xD;
      for age and ECG presentation. Matching will be performed locally, in each study site&#xD;
      (hospital). All patients will undergo 1-year follow-up with clinical and therapeutic&#xD;
      adherence evaluation.&#xD;
&#xD;
      - Reference cohort: 500 women discharged alive after a hospitalization for a type 1 acute&#xD;
      myocardial infarction with significant coronary artery disease.&#xD;
&#xD;
      - Comparator cohort: 500 age (±2 years) and ECG (ST-segment elevation acute myocardial&#xD;
      infarction (STEMI) / non-ST-segment elevation acute myocardial infarction (NSTEMI)) locally&#xD;
      matched men discharged alive after a hospitalization for a type 1 acute myocardial infarction&#xD;
      with significant coronary artery disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES&#xD;
&#xD;
      General objective: To evaluate if there are differences in the level of adherence to&#xD;
      recommended secondary prevention therapies (pharmacological and non-pharmacological) between&#xD;
      women and men surviving a type 1 acute myocardial infarction (with obstructive coronary&#xD;
      artery disease), its potential consequences, and the potential factors related to that&#xD;
      difference, if present.&#xD;
&#xD;
      Specific objectives: To compare between women and men:&#xD;
&#xD;
      1) The adherence to recommended secondary prevention therapies at 6 months and 12 months&#xD;
      measured as the:&#xD;
&#xD;
      1a. Proportion of patients adherent to all recommended pharmacological secondary prevention&#xD;
      therapies at 6 and 12 months.&#xD;
&#xD;
      1b. Proportion of patients adherent to all recommended non-pharmacological secondary&#xD;
      prevention therapies at 6 and 12 months.&#xD;
&#xD;
      2) The relationship of the adherence with control of risk factors, clinical outcomes, and use&#xD;
      of healthcare resources.&#xD;
&#xD;
      2a. The proportion of patients with optimal control of all cardiovascular risk factors at 6&#xD;
      and 12 months.&#xD;
&#xD;
      2b. The incidence of clinical outcomes at 6 and 12 months. 2c. The cumulative use of&#xD;
      healthcare resources and cost after discharge.&#xD;
&#xD;
      3) To assess the factors associated with non-adherence to recommended secondary prevention&#xD;
      therapies, with special emphasis to socioeconomic factors and gender issues.&#xD;
&#xD;
      STUDY DESIGN&#xD;
&#xD;
      DESIGN:&#xD;
&#xD;
      Prospective, matched cohort study of patients hospitalized for a type 1 acute myocardial&#xD;
      infarction with evidence of obstructive coronary artery disease who are discharged home&#xD;
      alive. Women will be enrolled first, ideally in a consecutive manner, as they are the focus&#xD;
      of the study. Men will be recruited subsequently as the comparison group, with 1:1 matching&#xD;
      for age and ECG presentation. Matching will be performed locally, in each study site&#xD;
      (hospital). All patients will undergo 1-year follow-up with clinical and therapeutic&#xD;
      adherence evaluation.&#xD;
&#xD;
      RECRUITMENT:&#xD;
&#xD;
      Participant centers:&#xD;
&#xD;
      25 hospitals managing routinely acute myocardial infarction and representing different&#xD;
      regions from Spain will be invited to participate.&#xD;
&#xD;
      Patient recruitment:&#xD;
&#xD;
      All consecutive women fulfilling all inclusion criteria and without exclusion criteria&#xD;
      surviving the index hospitalization will be invited to participate. Subsequently, men with&#xD;
      inclusion criteria and without exclusion criteria, matched for age and ECG presentation, will&#xD;
      be recruited.&#xD;
&#xD;
      STATISTICAL ANALYSIS:&#xD;
&#xD;
      A minimum sample size of 820 participants (410 per group) was estimated for an expected&#xD;
      relative difference in recommendations compliance of the all-or-none composite primary&#xD;
      outcome of 20%. An α error of 0.05 and a β error of 0.20 were considered for the sample size.&#xD;
      The recommendations compliance was estimated as 42% for women and 52% for men. With the&#xD;
      consideration of 20% of lost to follow-up (discontinuations) the total sample size is 984&#xD;
      patients, which is rounded out to 1000 patients (500 women and 500 men). To increase regional&#xD;
      representation and allow exploration of potential regional variability, 25 hospitals from all&#xD;
      regions in Spain (17 Autonomous Communities) will be invited to participate.&#xD;
&#xD;
      For the description of continuous variables, mean and standard deviation, or median and&#xD;
      interquartile range will be used for Gaussian and non-normal distributions, respectively. For&#xD;
      describing categorical variables, frequencies and percentages per category will be used.&#xD;
      Categorical variables will be compared using the chi2 test, whilst continuous variables will&#xD;
      be compared using the student t test.&#xD;
&#xD;
      Logistic regression models will be used to evaluate differences in binary outcomes between&#xD;
      women and men (in hospital acute myocardial infarction management, post discharge myocardial&#xD;
      infarction management). All subjects will be assumed to have a fixed follow-up (12±1 month).&#xD;
      Multivariate adjusted models will be used to address any potential confounding in the&#xD;
      associations between sex and each of the outcomes. Covariates will be selected based on their&#xD;
      pre-defined clinical value and the unbalances observed across groups in the univariate&#xD;
      analyses. Linear, multinomial or ordinal regression models would be used in case of&#xD;
      continuous, categorical, or ordinal outcomes, respectively.&#xD;
&#xD;
      In addition to the models evaluating the association between sex and outcomes, a predictive&#xD;
      model will be conducted to set predictors for the following outcomes:&#xD;
&#xD;
        1. a composite of all preventive therapies (all-or-nothing for diet, physical activity,&#xD;
           P2Y12 inhibitors, statins, and beta blockers or angiotensin converting enzyme inhibitors&#xD;
           [if prescribed at discharge]), and&#xD;
&#xD;
        2. each group of preventive interventions (drugs, cardiac rehab, diet, physical activity)&#xD;
           Candidate predictors are classified as biological factors (age, sex, risk factors,&#xD;
           comorbidities), disease-related (type of myocardial infarction: ST-segment elevation&#xD;
           acute myocardial infarction (STEMI) / non-ST-segment elevation acute myocardial&#xD;
           infarction (NSTEMI), left ventricular ejection fraction, number of vessels…),&#xD;
           pharmacological factors (daily number of drugs, daily number of doses, specific drugs),&#xD;
           socio-economic factors (zip code, education level, employment status, wages…) and&#xD;
           specific gender issues (family responsibilities, work conciliation…). Special&#xD;
           consideration will be given to age due to the high figures of in-hospital mortality in&#xD;
           young women.&#xD;
&#xD;
      For women-specific analysis, female specific factors (menarche age, pregnancies, gestational&#xD;
      diabetes, menopause…) will be considered.&#xD;
&#xD;
      It will be used the Clinical Outcomes, HEalthcare REsource UtilizatioN, and relaTed costs&#xD;
      (COHERENT) model to study the hospital-related healthcare resources (emergency department&#xD;
      visits, specialist visits, re-hospitalizations and urgent procedures) and costs.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 8, 2023</start_date>
  <completion_date type="Anticipated">June 2024</completion_date>
  <primary_completion_date type="Anticipated">June 2024</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Composite outcome of adherence to all secondary cardiovascular prevention recommendations at 12 months after discharge</measure>
    <time_frame>12 months</time_frame>
    <description>The composite is built as an all-or-nothing response to an adherence ≥80% in all prescribed components of the endpoint: pharmacological therapies (MMAS-8), diet, physical activity and participation in a cardiac rehabilitation program. Adherence will be defined as having at least 80% compliance with all cardiovascular prevention recommendations; drugs, cardiac rehabilitation program, diet and physical activity)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pharmacological primary endpoint</measure>
    <time_frame>12 months</time_frame>
    <description>Outcome of adherence to pharmacological therapies (MMAS-8) 12 months after discharge</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Non-pharmacological primary endpoint</measure>
    <time_frame>12 months</time_frame>
    <description>Composite outcome of adherence to non-pharmacological secondary cardiovascular prevention recommendations 12 months after discharge, including diet, physical activity and participation in cardiac rehabilitation programs</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pharmacological primary endpoint</measure>
    <time_frame>6 months</time_frame>
    <description>Outcome of adherence to pharmacological therapies (MMAS-8) 6 months after discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-pharmacological primary endpoint</measure>
    <time_frame>6 months</time_frame>
    <description>Composite outcome of adherence to non-pharmacological secondary cardiovascular prevention recommendations 6 months after discharge, including diet, physical activity and participation in cardiac rehabilitation programs</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Gender Differences</condition>
  <condition>Adherence, Medication</condition>
  <condition>Therapeutic Adherence</condition>
  <condition>Type 1 Acute Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>500 women</arm_group_label>
    <description>500 women discharged alive after a hospitalization for a type 1 acute myocardial infarction with significant coronary artery disease.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>500 men</arm_group_label>
    <description>500 age (±2 years) and ECG (STEMI/NSTEMI) locally matched men discharged alive after a hospitalization for a type 1 acute myocardial infarction with significant coronary artery disease.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Prospective, matched cohort study of patients hospitalized for a type 1 AMI with evidence&#xD;
        of obstructive coronary artery disease who are discharged home alive. Women will be&#xD;
        enrolled first, ideally in a consecutive manner, as they are the focus of the study. Men&#xD;
        will be recruited subsequently as the comparison group, with 1:1 matching for age and ECG&#xD;
        presentation. Matching will be performed locally, in each study site (hospital). All&#xD;
        patients will undergo 1-year follow-up with clinical and therapeutic adherence evaluation.&#xD;
&#xD;
        Reference cohort: 500 women discharged alive after a hospitalization for a type 1 AMI with&#xD;
        significant CAD.&#xD;
&#xD;
        Comparator cohort: 500 age (±2 years) and ECG (STEMI/NSTEMI) locally matched men discharged&#xD;
        alive after a hospitalization for a type 1 AMI with significant CAD.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Hospitalization for a type 1 acute myocardial infarction (detection of a rise and/or&#xD;
             fall of troponin c value above the 99th percentile upper reference limit (URL) and&#xD;
             with at least one of the followings: symptoms of acute myocardial ischemia; new&#xD;
             ischaemic ECG changes; development of pathological Q waves; imaging evidence of new&#xD;
             loss of viable myocardium or new regional wall motion abnormality in a patterns&#xD;
             consistent with an ischaemic aetiology; identification of a coronary thrombus by&#xD;
             angiography including intracoronary imaging)&#xD;
&#xD;
          -  Presence of obstructive coronary artery disease (CAD) (i.e. coronary artery stenosis&#xD;
             ≥50%)&#xD;
&#xD;
          -  Age &gt;18 years. No maximal age limit applies&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Terminal disease (expected survival &lt;12 months)&#xD;
&#xD;
          -  Unavailable for 12-month follow-up (i.e.: living abroad, social situation…)&#xD;
&#xD;
          -  Does not speak Spanish&#xD;
&#xD;
          -  Major active comorbidity (severe renal or liver failure, active cancer requiring&#xD;
             chemotherapy…), interfering with regular post-myocardial infarction management&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hector Bueno, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario 12 de Octubre, Madrid</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hector Bueno, MD, PhD</last_name>
    <phone>981 216 391</phone>
    <email>proyectos@odds.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario de Santiago de Compostela</name>
      <address>
        <city>Santiago De Compostela</city>
        <state>A Coruña</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Milagros Pedreira Pérez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <state>Asturias</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rut Álvarez Velasco</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Son Espases, Palma de Mallorca</name>
      <address>
        <city>Palma de Mallorca</city>
        <state>Baleares</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Roselló Lozano</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Marqués de Valdecilla</name>
      <address>
        <city>Santander</city>
        <state>Cantabria</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gonzalo Martín Gorria</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Gran Canaria Dr. Negrín</name>
      <address>
        <city>Las Palmas De Gran Canaria</city>
        <state>Las Palmas</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafaela Ramírez Rodríguez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Fundación Alcorcón</name>
      <address>
        <city>Alcorcón</city>
        <state>Madrid</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raquel Campuzano Ruiz</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de Navarra</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aitziber Munarriz Arizcuren</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Álvaro Cunqueiro de Vigo</name>
      <address>
        <city>Vigo</city>
        <state>Pontevedra</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sergio Raposeiras Roubín</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario de Canarias, La Laguna</name>
      <address>
        <city>La Laguna</city>
        <state>Tenerife</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pablo Jorge Pérez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Áraba/Txagorritxu</name>
      <address>
        <city>Gasteiz / Vitoria</city>
        <state>Vitoria</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucas Tojal Sierra</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Basurto</name>
      <address>
        <city>Bilbao</city>
        <state>Vizcaya</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abel Andrés Morist</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario Universitario de Albacete</name>
      <address>
        <city>Albacete</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Miguel Corbí Pascual</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Alicante</name>
      <address>
        <city>Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miriam Sandín Rollán</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Bellvitge</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Albert Ariza</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Vall´d Hebron</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonia Sambola Ayala</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital San Pedro de Alcántara</name>
      <address>
        <city>Cáceres</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Javier Gómez Barrado</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complejo Asistencial Universitario de León</name>
      <address>
        <city>León</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norberto Alonso Orcajo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lourdes Vicent Alaminos</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Arrixaca</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Domingo Pascual Figal</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Victoria</name>
      <address>
        <city>Málaga</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan José Gómez Doblas</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Elvira Laffond</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>María del Mar Martínez Quesada</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complejo Hospitalario de Toledo</name>
      <address>
        <city>Toledo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Álvarez Sánchez</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario de Valencia</name>
      <address>
        <city>Valencia</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Sanchís Fores</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario Lozano Blesa</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pablo Revilla Martí</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R. Mortality From Ischemic Heart Disease. Circ Cardiovasc Qual Outcomes. 2019 Jun;12(6):e005375. doi: 10.1161/CIRCOUTCOMES.118.005375. Epub 2019 Jun 4.</citation>
    <PMID>31163980</PMID>
  </reference>
  <reference>
    <citation>Maas AHEM, Rosano G, Cifkova R, Chieffo A, van Dijken D, Hamoda H, Kunadian V, Laan E, Lambrinoudaki I, Maclaran K, Panay N, Stevenson JC, van Trotsenburg M, Collins P. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. Eur Heart J. 2021 Mar 7;42(10):967-984. doi: 10.1093/eurheartj/ehaa1044. Erratum In: Eur Heart J. 2022 Jul 1;43(25):2372.</citation>
    <PMID>33495787</PMID>
  </reference>
  <reference>
    <citation>Jagannathan R, Patel SA, Ali MK, Narayan KMV. Global Updates on Cardiovascular Disease Mortality Trends and Attribution of Traditional Risk Factors. Curr Diab Rep. 2019 Jun 20;19(7):44. doi: 10.1007/s11892-019-1161-2.</citation>
    <PMID>31222515</PMID>
  </reference>
  <reference>
    <citation>Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O'Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659. No abstract available. Erratum In: Circulation. 2020 Jan 14;141(2):e33.</citation>
    <PMID>30700139</PMID>
  </reference>
  <reference>
    <citation>Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010 Jun 10;362(23):2155-65. doi: 10.1056/NEJMoa0908610.</citation>
    <PMID>20558366</PMID>
  </reference>
  <reference>
    <citation>Neumann JT, Gossling A, Sorensen NA, Blankenberg S, Magnussen C, Westermann D. Temporal trends in incidence and outcome of acute coronary syndrome. Clin Res Cardiol. 2020 Sep;109(9):1186-1192. doi: 10.1007/s00392-020-01612-1. Epub 2020 Feb 7.</citation>
    <PMID>32034482</PMID>
  </reference>
  <reference>
    <citation>Chi GC, Kanter MH, Li BH, Qian L, Reading SR, Harrison TN, Jacobsen SJ, Scott RD, Cavendish JJ, Lawrence JM, Tartof SY, Reynolds K. Trends in Acute Myocardial Infarction by Race and Ethnicity. J Am Heart Assoc. 2020 Mar 3;9(5):e013542. doi: 10.1161/JAHA.119.013542. Epub 2020 Mar 2.</citation>
    <PMID>32114888</PMID>
  </reference>
  <reference>
    <citation>Goldberg RJ, Tisminetzky M, Tran HV, Yarzebski J, Lessard D, Gore JM. Decade Long Trends (2001-2011) in the Incidence Rates of Initial Acute Myocardial Infarction. Am J Cardiol. 2019 Jan 15;123(2):206-211. doi: 10.1016/j.amjcard.2018.10.002. Epub 2018 Oct 19.</citation>
    <PMID>30409411</PMID>
  </reference>
  <reference>
    <citation>Bangalore S, Fonarow GC, Peterson ED, Hellkamp AS, Hernandez AF, Laskey W, Peacock WF, Cannon CP, Schwamm LH, Bhatt DL; Get with the Guidelines Steering Committee and Investigators. Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction. Am J Med. 2012 Oct;125(10):1000-9. doi: 10.1016/j.amjmed.2011.11.016. Epub 2012 Jun 27.</citation>
    <PMID>22748404</PMID>
  </reference>
  <reference>
    <citation>Bossard M, Latifi Y, Fabbri M, Kurmann R, Brinkert M, Wolfrum M, Berte B, Cuculi F, Toggweiler S, Kobza R, Chamberlain AM, Moccetti F. Increasing Mortality From Premature Coronary Artery Disease in Women in the Rural United States. J Am Heart Assoc. 2020 May 5;9(9):e015334. doi: 10.1161/JAHA.119.015334. Epub 2020 Apr 22.</citation>
    <PMID>32316803</PMID>
  </reference>
  <reference>
    <citation>Arora S, Stouffer GA, Kucharska-Newton AM, Qamar A, Vaduganathan M, Pandey A, Porterfield D, Blankstein R, Rosamond WD, Bhatt DL, Caughey MC. Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction. Circulation. 2019 Feb 19;139(8):1047-1056. doi: 10.1161/CIRCULATIONAHA.118.037137.</citation>
    <PMID>30586725</PMID>
  </reference>
  <reference>
    <citation>Wu WY, Berman AN, Biery DW, Blankstein R. Recent trends in acute myocardial infarction among the young. Curr Opin Cardiol. 2020 Sep;35(5):524-530. doi: 10.1097/HCO.0000000000000781.</citation>
    <PMID>32694263</PMID>
  </reference>
  <reference>
    <citation>Rodriguez-Padial L, Fernandez-Perez C, Bernal JL, Anguita M, Sambola A, Fernandez-Ortiz A, Elola FJ. Differences in in-hospital mortality after STEMI versus NSTEMI by sex. Eleven-year trend in the Spanish National Health Service. Rev Esp Cardiol (Engl Ed). 2021 Jun;74(6):510-517. doi: 10.1016/j.rec.2020.04.017. Epub 2020 Jun 16. English, Spanish.</citation>
    <PMID>32561143</PMID>
  </reference>
  <reference>
    <citation>Cortes-Beringola A, Fitzsimons D, Pelliccia A, Moreno G, Martin-Asenjo R, Bueno H. Planning secondary prevention: Room for improvement. Eur J Prev Cardiol. 2017 Jun;24(3_suppl):22-28. doi: 10.1177/2047487317704954.</citation>
    <PMID>28618903</PMID>
  </reference>
  <reference>
    <citation>Mehta LS, Beckie TM, DeVon HA, Grines CL, Krumholz HM, Johnson MN, Lindley KJ, Vaccarino V, Wang TY, Watson KE, Wenger NK; American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Cardiovascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research. Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association. Circulation. 2016 Mar 1;133(9):916-47. doi: 10.1161/CIR.0000000000000351. Epub 2016 Jan 25.</citation>
    <PMID>26811316</PMID>
  </reference>
  <reference>
    <citation>Woodward M. Cardiovascular Disease and the Female Disadvantage. Int J Environ Res Public Health. 2019 Apr 1;16(7):1165. doi: 10.3390/ijerph16071165.</citation>
    <PMID>30939754</PMID>
  </reference>
  <reference>
    <citation>Hyun KK, Redfern J, Patel A, Peiris D, Brieger D, Sullivan D, Harris M, Usherwood T, MacMahon S, Lyford M, Woodward M. Gender inequalities in cardiovascular risk factor assessment and management in primary healthcare. Heart. 2017 Apr;103(7):492-498. doi: 10.1136/heartjnl-2016-310216. Epub 2017 Mar 1.</citation>
    <PMID>28249996</PMID>
  </reference>
  <reference>
    <citation>Young L, Cho L. Unique cardiovascular risk factors in women. Heart. 2019 Nov;105(21):1656-1660. doi: 10.1136/heartjnl-2018-314268. Epub 2019 Jul 17.</citation>
    <PMID>31315936</PMID>
  </reference>
  <reference>
    <citation>Gao Z, Chen Z, Sun A, Deng X. Gender differences in cardiovascular disease. Medicine in Novel Technology and Devices. 2019;4:100025.</citation>
  </reference>
  <reference>
    <citation>EUGenMed Cardiovascular Clinical Study Group; Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E, Franconi F, Gerdts E, Foryst-Ludwig A, Maas AH, Kautzky-Willer A, Knappe-Wegner D, Kintscher U, Ladwig KH, Schenck-Gustafsson K, Stangl V. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016 Jan 1;37(1):24-34. doi: 10.1093/eurheartj/ehv598. Epub 2015 Nov 3. No abstract available.</citation>
    <PMID>26530104</PMID>
  </reference>
  <reference>
    <citation>Regitz-Zagrosek V, Kararigas G. Mechanistic Pathways of Sex Differences in Cardiovascular Disease. Physiol Rev. 2017 Jan;97(1):1-37. doi: 10.1152/physrev.00021.2015.</citation>
    <PMID>27807199</PMID>
  </reference>
  <reference>
    <citation>Gerdts E, Regitz-Zagrosek V. Sex differences in cardiometabolic disorders. Nat Med. 2019 Nov;25(11):1657-1666. doi: 10.1038/s41591-019-0643-8. Epub 2019 Nov 7.</citation>
    <PMID>31700185</PMID>
  </reference>
  <reference>
    <citation>Peters SA, Woodward M. Women's reproductive factors and incident cardiovascular disease in the UK Biobank. Heart. 2018 Jul;104(13):1069-1075. doi: 10.1136/heartjnl-2017-312289. Epub 2018 Jan 15.</citation>
    <PMID>29335253</PMID>
  </reference>
  <reference>
    <citation>Agarwala A, Michos ED, Samad Z, Ballantyne CM, Virani SS. The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk. Circulation. 2020 Feb 18;141(7):592-599. doi: 10.1161/CIRCULATIONAHA.119.043429. Epub 2020 Feb 17.</citation>
    <PMID>32065772</PMID>
  </reference>
  <reference>
    <citation>Torris C, Bjornnes AK. Duration of Lactation and Maternal Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis. Nutrients. 2020 Sep 5;12(9):2718. doi: 10.3390/nu12092718.</citation>
    <PMID>32899507</PMID>
  </reference>
  <reference>
    <citation>Hayward CS, Kelly RP, Collins P. The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res. 2000 Apr;46(1):28-49. doi: 10.1016/s0008-6363(00)00005-5. No abstract available.</citation>
    <PMID>10727651</PMID>
  </reference>
  <reference>
    <citation>Parker WH, Jacoby V, Shoupe D, Rocca W. Effect of bilateral oophorectomy on women's long-term health. Womens Health (Lond). 2009 Sep;5(5):565-76. doi: 10.2217/whe.09.42.</citation>
    <PMID>19702455</PMID>
  </reference>
  <reference>
    <citation>Smith SB, Geske JB, Kathuria P, Cuttica M, Schimmel DR, Courtney DM, Waterer GW, Wunderink RG. Analysis of National Trends in Admissions for Pulmonary Embolism. Chest. 2016 Jul;150(1):35-45. doi: 10.1016/j.chest.2016.02.638. Epub 2016 Feb 18.</citation>
    <PMID>26905364</PMID>
  </reference>
  <reference>
    <citation>Rosvall M, Gerward S, Engstrom G, Hedblad B. Income and short-term case fatality after myocardial infarction in the whole middle-aged population of Malmo, Sweden. Eur J Public Health. 2008 Oct;18(5):533-8. doi: 10.1093/eurpub/ckn059. Epub 2008 Jul 11.</citation>
    <PMID>18621776</PMID>
  </reference>
  <reference>
    <citation>Coughlin SS, Young L. Social Determinants of Myocardial Infarction Risk and Survival: A Systematic Review. Eur j Cardiovasc Res. 2020;1(1):10.31487/j.ejcr.2020.01.02. doi: 10.31487/j.ejcr.2020.01.02. Epub 2020 Sep 18.</citation>
    <PMID>33089252</PMID>
  </reference>
  <reference>
    <citation>Deguen S, Lalloue B, Bard D, Havard S, Arveiler D, Zmirou-Navier D. A small-area ecologic study of myocardial infarction, neighborhood deprivation, and sex: a Bayesian modeling approach. Epidemiology. 2010 Jul;21(4):459-66. doi: 10.1097/EDE.0b013e3181e09925.</citation>
    <PMID>20489648</PMID>
  </reference>
  <reference>
    <citation>Koopman C, van Oeffelen AA, Bots ML, Engelfriet PM, Verschuren WM, van Rossem L, van Dis I, Capewell S, Vaartjes I. Neighbourhood socioeconomic inequalities in incidence of acute myocardial infarction: a cohort study quantifying age- and gender-specific differences in relative and absolute terms. BMC Public Health. 2012 Aug 7;12:617. doi: 10.1186/1471-2458-12-617.</citation>
    <PMID>22870916</PMID>
  </reference>
  <reference>
    <citation>Peterson PN. JAHA Spotlight on Psychosocial Factors and Cardiovascular Disease. J Am Heart Assoc. 2020 May 5;9(9):e017112. doi: 10.1161/JAHA.120.017112. Epub 2020 Apr 28. No abstract available.</citation>
    <PMID>32342721</PMID>
  </reference>
  <reference>
    <citation>Greaney JL, Koffer RE, Saunders EFH, Almeida DM, Alexander LM. Self-Reported Everyday Psychosocial Stressors Are Associated With Greater Impairments in Endothelial Function in Young Adults With Major Depressive Disorder. J Am Heart Assoc. 2019 Feb 19;8(4):e010825. doi: 10.1161/JAHA.118.010825.</citation>
    <PMID>30741602</PMID>
  </reference>
  <reference>
    <citation>Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999 Apr 27;99(16):2192-217. doi: 10.1161/01.cir.99.16.2192.</citation>
    <PMID>10217662</PMID>
  </reference>
  <reference>
    <citation>Greaney JL, Surachman A, Saunders EFH, Alexander LM, Almeida DM. Greater Daily Psychosocial Stress Exposure is Associated With Increased Norepinephrine-Induced Vasoconstriction in Young Adults. J Am Heart Assoc. 2020 May 5;9(9):e015697. doi: 10.1161/JAHA.119.015697. Epub 2020 Apr 28.</citation>
    <PMID>32340506</PMID>
  </reference>
  <reference>
    <citation>Mittleman MA, Maclure M, Sherwood JB, Mulry RP, Tofler GH, Jacobs SC, Friedman R, Benson H, Muller JE. Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators. Circulation. 1995 Oct 1;92(7):1720-5. doi: 10.1161/01.cir.92.7.1720.</citation>
    <PMID>7671353</PMID>
  </reference>
  <reference>
    <citation>Nabi H, Kivimaki M, Batty GD, Shipley MJ, Britton A, Brunner EJ, Vahtera J, Lemogne C, Elbaz A, Singh-Manoux A. Increased risk of coronary heart disease among individuals reporting adverse impact of stress on their health: the Whitehall II prospective cohort study. Eur Heart J. 2013 Sep;34(34):2697-705. doi: 10.1093/eurheartj/eht216. Epub 2013 Jun 26.</citation>
    <PMID>23804585</PMID>
  </reference>
  <reference>
    <citation>Molarius A, Metsini A. Domestic Work, Self-Reported Diagnosed Depression and Related Costs among Women and Men-Results from a Population-Based Study in Sweden. Int J Environ Res Public Health. 2021 Sep 16;18(18):9778. doi: 10.3390/ijerph18189778.</citation>
    <PMID>34574699</PMID>
  </reference>
  <reference>
    <citation>Lundberg U, Mardberg B, Frankenhaeuser M. The total workload of male and female white collar workers as related to age, occupational level, and number of children. Scand J Psychol. 1994 Dec;35(4):315-27. doi: 10.1111/j.1467-9450.1994.tb00956.x.</citation>
    <PMID>7809584</PMID>
  </reference>
  <reference>
    <citation>Vaccarino V, Shah AJ, Rooks C, Ibeanu I, Nye JA, Pimple P, Salerno A, D'Marco L, Karohl C, Bremner JD, Raggi P. Sex differences in mental stress-induced myocardial ischemia in young survivors of an acute myocardial infarction. Psychosom Med. 2014 Apr;76(3):171-80. doi: 10.1097/PSY.0000000000000045.</citation>
    <PMID>24608039</PMID>
  </reference>
  <reference>
    <citation>Rossello X, Mas-Llado C, Pocock S, Vicent L, van de Werf F, Chin CT, Danchin N, Lee SWL, Medina J, Huo Y, Bueno H. Sex differences in mortality after an acute coronary syndrome increase with lower country wealth and higher income inequality. Rev Esp Cardiol (Engl Ed). 2022 May;75(5):392-400. doi: 10.1016/j.rec.2021.05.006. Epub 2021 Jun 24. English, Spanish.</citation>
    <PMID>34175245</PMID>
  </reference>
  <reference>
    <citation>Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, Vaccarino V, Wulsin L; American Heart Association Statistics Committee of the Council on Epidemiology and Prevention and the Council on Cardiovascular and Stroke Nursing. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014 Mar 25;129(12):1350-69. doi: 10.1161/CIR.0000000000000019. Epub 2014 Feb 24.</citation>
    <PMID>24566200</PMID>
  </reference>
  <reference>
    <citation>Smolderen KG, Strait KM, Dreyer RP, D'Onofrio G, Zhou S, Lichtman JH, Geda M, Bueno H, Beltrame J, Safdar B, Krumholz HM, Spertus JA. Depressive symptoms in younger women and men with acute myocardial infarction: insights from the VIRGO study. J Am Heart Assoc. 2015 Apr 2;4(4):e001424. doi: 10.1161/JAHA.114.001424.</citation>
    <PMID>25836055</PMID>
  </reference>
  <reference>
    <citation>Rossi AM, Pilote L. Let's Talk About Sex...and Gender! Circ Cardiovasc Qual Outcomes. 2016 Feb;9(2 Suppl 1):S100-1. doi: 10.1161/CIRCOUTCOMES.116.002660. No abstract available.</citation>
    <PMID>26908854</PMID>
  </reference>
  <reference>
    <citation>Wu J, Gale CP, Hall M, Dondo TB, Metcalfe E, Oliver G, Batin PD, Hemingway H, Timmis A, West RM. Editor's Choice - Impact of initial hospital diagnosis on mortality for acute myocardial infarction: A national cohort study. Eur Heart J Acute Cardiovasc Care. 2018 Mar;7(2):139-148. doi: 10.1177/2048872616661693. Epub 2016 Aug 29.</citation>
    <PMID>27574333</PMID>
  </reference>
  <reference>
    <citation>Bugiardini R, Ricci B, Cenko E, Vasiljevic Z, Kedev S, Davidovic G, Zdravkovic M, Milicic D, Dilic M, Manfrini O, Koller A, Badimon L. Delayed Care and Mortality Among Women and Men With Myocardial Infarction. J Am Heart Assoc. 2017 Aug 21;6(8):e005968. doi: 10.1161/JAHA.117.005968.</citation>
    <PMID>28862963</PMID>
  </reference>
  <reference>
    <citation>Ahmed B, Dauerman HL. Women, bleeding, and coronary intervention. Circulation. 2013 Feb 5;127(5):641-9. doi: 10.1161/CIRCULATIONAHA.112.108290. No abstract available.</citation>
    <PMID>23381962</PMID>
  </reference>
  <reference>
    <citation>Damluji AA, van Diepen S, Katz JN, Menon V, Tamis-Holland JE, Bakitas M, Cohen MG, Balsam LB, Chikwe J; American Heart Association Council on Clinical Cardiology; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Surgery and Anesthesia; and Council on Cardiovascular and Stroke Nursing. Mechanical Complications of Acute Myocardial Infarction: A Scientific Statement From the American Heart Association. Circulation. 2021 Jul 13;144(2):e16-e35. doi: 10.1161/CIR.0000000000000985. Epub 2021 Jun 15.</citation>
    <PMID>34126755</PMID>
  </reference>
  <reference>
    <citation>Kuehnemund L, Koeppe J, Feld J, Wiederhold A, Illner J, Makowski L, Gerss J, Reinecke H, Freisinger E. Gender differences in acute myocardial infarction-A nationwide German real-life analysis from 2014 to 2017. Clin Cardiol. 2021 Jul;44(7):890-898. doi: 10.1002/clc.23662. Epub 2021 Jun 1.</citation>
    <PMID>34075604</PMID>
  </reference>
  <reference>
    <citation>Matetic A, Shamkhani W, Rashid M, Volgman AS, Van Spall HGC, Coutinho T, Mehta LS, Sharma G, Parwani P, Mohamed MO, Mamas MA. Trends of Sex Differences in Clinical Outcomes After Myocardial Infarction in the United States. CJC Open. 2021 Jul 1;3(12 Suppl):S19-S27. doi: 10.1016/j.cjco.2021.06.012. eCollection 2021 Dec.</citation>
    <PMID>34993430</PMID>
  </reference>
  <reference>
    <citation>Eindhoven DC, Hilt AD, Zwaan TC, Schalij MJ, Borleffs CJW. Age and gender differences in medical adherence after myocardial infarction: Women do not receive optimal treatment - The Netherlands claims database. Eur J Prev Cardiol. 2018 Jan;25(2):181-189. doi: 10.1177/2047487317744363. Epub 2017 Nov 22.</citation>
    <PMID>29164916</PMID>
  </reference>
  <reference>
    <citation>Hyun K, Negrone A, Redfern J, Atkins E, Chow C, Kilian J, Rajaratnam R, Brieger D. Gender Difference in Secondary Prevention of Cardiovascular Disease and Outcomes Following the Survival of Acute Coronary Syndrome. Heart Lung Circ. 2021 Jan;30(1):121-127. doi: 10.1016/j.hlc.2020.06.026. Epub 2020 Sep 2.</citation>
    <PMID>32888821</PMID>
  </reference>
  <reference>
    <citation>Gulati M, Hendry C, Parapid B, Mulvagh SL. Why We Need Specialised Centres for Women's Hearts: Changing the Face of Cardiovascular Care for Women. Eur Cardiol. 2021 Dec 9;16:e52. doi: 10.15420/ecr.2021.49. eCollection 2021 Feb.</citation>
    <PMID>35024054</PMID>
  </reference>
  <reference>
    <citation>Smolina K, Ball L, Humphries KH, Khan N, Morgan SG. Sex Disparities in Post-Acute Myocardial Infarction Pharmacologic Treatment Initiation and Adherence: Problem for Young Women. Circ Cardiovasc Qual Outcomes. 2015 Nov;8(6):586-92. doi: 10.1161/CIRCOUTCOMES.115.001987. Epub 2015 Oct 13.</citation>
    <PMID>26462876</PMID>
  </reference>
  <reference>
    <citation>Hao Y, Liu J, Liu J, Yang N, Smith SC Jr, Huo Y, Fonarow GC, Ge J, Taubert KA, Morgan L, Zhou M, Xing Y, Ma CS, Han Y, Zhao D. Sex Differences in In-Hospital Management and Outcomes of Patients With Acute Coronary Syndrome. Circulation. 2019 Apr 9;139(15):1776-1785. doi: 10.1161/CIRCULATIONAHA.118.037655.</citation>
    <PMID>30667281</PMID>
  </reference>
  <reference>
    <citation>Dagan M, Dinh DT, Stehli J, Tan C, Brennan A, Warren J, Ajani AE, Freeman M, Murphy A, Reid CM, Hiew C, Oqueli E, Clark DJ, Duffy SJ. Sex disparity in secondary prevention pharmacotherapy and clinical outcomes following acute coronary syndrome. Eur Heart J Qual Care Clin Outcomes. 2022 Jun 6;8(4):420-428. doi: 10.1093/ehjqcco/qcab007.</citation>
    <PMID>33537698</PMID>
  </reference>
  <reference>
    <citation>Witt BJ, Jacobsen SJ, Weston SA, Killian JM, Meverden RA, Allison TG, Reeder GS, Roger VL. Cardiac rehabilitation after myocardial infarction in the community. J Am Coll Cardiol. 2004 Sep 1;44(5):988-96. doi: 10.1016/j.jacc.2004.05.062.</citation>
    <PMID>15337208</PMID>
  </reference>
  <reference>
    <citation>Crnko S, Du Pre BC, Sluijter JPG, Van Laake LW. Circadian rhythms and the molecular clock in cardiovascular biology and disease. Nat Rev Cardiol. 2019 Jul;16(7):437-447. doi: 10.1038/s41569-019-0167-4.</citation>
    <PMID>30796369</PMID>
  </reference>
  <reference>
    <citation>Heras M. [Ischemic heart disease in women: clinical presentation, non-invasive testing and management of acute coronary syndromes]. Rev Esp Cardiol. 2006 Apr;59(4):371-81. Spanish.</citation>
    <PMID>16709390</PMID>
  </reference>
  <reference>
    <citation>Hamood H, Hamood R, Green MS, Almog R. Determinants of adherence to evidence-based therapy after acute myocardial infarction. Eur J Prev Cardiol. 2016 Jun;23(9):975-85. doi: 10.1177/2047487315597209. Epub 2015 Jul 21.</citation>
    <PMID>26198723</PMID>
  </reference>
  <reference>
    <citation>Zhu B, Zhao Z, McCollam P, Anderson J, Bae JP, Fu H, Zettler M, Lenarz L. Factors associated with clopidogrel use, adherence, and persistence in patients with acute coronary syndromes undergoing percutaneous coronary intervention. Curr Med Res Opin. 2011 Mar;27(3):633-41. doi: 10.1185/03007995.2010.551657. Epub 2011 Jan 18.</citation>
    <PMID>21241206</PMID>
  </reference>
  <reference>
    <citation>Lewey J, Shrank WH, Bowry AD, Kilabuk E, Brennan TA, Choudhry NK. Gender and racial disparities in adherence to statin therapy: a meta-analysis. Am Heart J. 2013 May;165(5):665-78, 678.e1. doi: 10.1016/j.ahj.2013.02.011. Epub 2013 Mar 26.</citation>
    <PMID>23622903</PMID>
  </reference>
  <reference>
    <citation>Kumbhani DJ, Fonarow GC, Cannon CP, Hernandez AF, Peterson ED, Peacock WF, Laskey WK, Pan W, Schwamm LH, Bhatt DL; Get With the Guidelines Steering Committee and Investigators. Predictors of adherence to performance measures in patients with acute myocardial infarction. Am J Med. 2013 Jan;126(1):74.e1-9. doi: 10.1016/j.amjmed.2012.02.025. Epub 2012 Aug 24.</citation>
    <PMID>22925314</PMID>
  </reference>
  <reference>
    <citation>Bots SH, Inia JA, Peters SAE. Medication Adherence After Acute Coronary Syndrome in Women Compared With Men: A Systematic Review and Meta-Analysis. Front Glob Womens Health. 2021 Feb 22;2:637398. doi: 10.3389/fgwh.2021.637398. eCollection 2021.</citation>
    <PMID>34816194</PMID>
  </reference>
  <reference>
    <citation>Sakalaki M, Barywani S, Rosengren A, Bjorck L, Fu M. Determinants of suboptimal long-term secondary prevention of acute myocardial infarction: the structural interview method and physical examinations. BMC Cardiovasc Disord. 2019 Nov 6;19(1):243. doi: 10.1186/s12872-019-1238-5.</citation>
    <PMID>31694556</PMID>
  </reference>
  <reference>
    <citation>Marques-Vidal P, Jankowski P, De Bacquer D, Kotseva K; EUROASPIRE V collaborators. Dietary measures among patients with coronary heart disease in Europe. ESC EORP Euroaspire V. Int J Cardiol. 2020 Mar 1;302:5-14. doi: 10.1016/j.ijcard.2019.12.064. Epub 2019 Dec 31.</citation>
    <PMID>31937454</PMID>
  </reference>
  <reference>
    <citation>Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264. doi: 10.1016/j.jacc.2018.08.1038. Epub 2018 Aug 25. No abstract available.</citation>
    <PMID>30153967</PMID>
  </reference>
  <reference>
    <citation>Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, De Caterina R, Zimarino M, Roffi M, Kjeldsen K, Atar D, Kaski JC, Sechtem U, Tornvall P; WG on Cardiovascular Pharmacotherapy. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017 Jan 14;38(3):143-153. doi: 10.1093/eurheartj/ehw149. No abstract available.</citation>
    <PMID>28158518</PMID>
  </reference>
  <reference>
    <citation>Schmidt S, Vilagut G, Garin O, Cunillera O, Tresserras R, Brugulat P, Mompart A, Medina A, Ferrer M, Alonso J. [Reference guidelines for the 12-Item Short-Form Health Survey version 2 based on the Catalan general population]. Med Clin (Barc). 2012 Dec 8;139(14):613-25. doi: 10.1016/j.medcli.2011.10.024. Epub 2012 Jan 11. Spanish.</citation>
    <PMID>22244683</PMID>
  </reference>
  <reference>
    <citation>Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.</citation>
    <PMID>6880820</PMID>
  </reference>
  <reference>
    <citation>Cantero MC, López-Roig S, Rodríguez-Marín J, Gelabert M, Pastor M-Á, Reig MT. Propiedades psicométricas de la Escala Hospitalaria de Ansiedad y Estrés (HAD) en población española. Ansiedad y Estrés. 2007;13:163-176</citation>
  </reference>
  <reference>
    <citation>Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980 Dec;20(6):649-55. doi: 10.1093/geront/20.6.649. No abstract available.</citation>
    <PMID>7203086</PMID>
  </reference>
  <reference>
    <citation>Martin-Carrasco M, Otermin P, Perez-Camo V, Pujol J, Aguera L, Martin MJ, Gobartt AL, Pons S, Balana M. EDUCA study: Psychometric properties of the Spanish version of the Zarit Caregiver Burden Scale. Aging Ment Health. 2010 Aug;14(6):705-11. doi: 10.1080/13607860903586094.</citation>
    <PMID>20544413</PMID>
  </reference>
  <reference>
    <citation>Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Back M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC National Cardiac Societies; ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484. No abstract available. Erratum In: Eur Heart J. 2022 Nov 7;43(42):4468.</citation>
    <PMID>34458905</PMID>
  </reference>
  <reference>
    <citation>Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008 May;10(5):348-54. doi: 10.1111/j.1751-7176.2008.07572.x.</citation>
    <PMID>18453793</PMID>
  </reference>
  <reference>
    <citation>Schroder H, Fito M, Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Lamuela-Raventos R, Ros E, Salaverria I, Fiol M, Lapetra J, Vinyoles E, Gomez-Gracia E, Lahoz C, Serra-Majem L, Pinto X, Ruiz-Gutierrez V, Covas MI. A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. J Nutr. 2011 Jun;141(6):1140-5. doi: 10.3945/jn.110.135566. Epub 2011 Apr 20.</citation>
    <PMID>21508208</PMID>
  </reference>
  <reference>
    <citation>Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. doi: 10.1249/01.MSS.0000078924.61453.FB.</citation>
    <PMID>12900694</PMID>
  </reference>
  <reference>
    <citation>Bueno H, Bernal JL, Jimenez-Jimenez V, Martin-Sanchez FJ, Rossello X, Moreno G, Goni C, Gil V, Llorens P, Naranjo N, Jacob J, Herrero-Puente P, Garrote S, Silla-Castro JC, Pocock SJ, Miro O; ICA-SEMES ad hoc COHERENT study group. The Clinical outcomes, healthcare resource utilization, and related costs (COHERENT) model. Application in heart failure patients. Rev Esp Cardiol (Engl Ed). 2022 Jul;75(7):585-594. doi: 10.1016/j.rec.2021.08.009. Epub 2021 Oct 20. English, Spanish.</citation>
    <PMID>34688580</PMID>
  </reference>
  <results_reference>
    <citation>Raparelli V, Norris CM, Bender U, Herrero MT, Kautzky-Willer A, Kublickiene K, El Emam K, Pilote L; GOING-FWD Collaborators. Identification and inclusion of gender factors in retrospective cohort studies: the GOING-FWD framework. BMJ Glob Health. 2021 Apr;6(4):e005413. doi: 10.1136/bmjgh-2021-005413.</citation>
    <PMID>33836996</PMID>
  </results_reference>
  <verification_date>April 2023</verification_date>
  <study_first_submitted>November 9, 2022</study_first_submitted>
  <study_first_submitted_qc>November 9, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2022</study_first_posted>
  <last_update_submitted>April 11, 2023</last_update_submitted>
  <last_update_submitted_qc>April 11, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Spanish Society of Cardiology</investigator_affiliation>
    <investigator_full_name>Héctor Bueno</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Gender</keyword>
  <keyword>Adherence</keyword>
  <keyword>Acute myocardial infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 22, 2022</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/01/NCT05619601/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

